Jörg Reinhardt to leave Bayer for Novartis
January 24, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Novartis, Reinhardt
The chairman of the Board and member of the Bayer executive council Dr Jörg Reinhard is stepping down from his …
Watson buys women’s health specialists
January 23, 2013Research and Development, Sales and Marketing Actavis, Uteron, Watson, women
Watson has completed the acquisition of Uteron Pharma, a Belgium R&D-based firm specialising in women’s health products. The world’s third-largest …
EU approval for meningitis vaccine
January 23, 2013Sales and Marketing Bexsero, CHMP, Novartis, meningitis
European regulators have approved Novartis’ Bexsero, making it the first broad coverage vaccine to target the leading cause of meningitis. …
New drug discovery alliance launches
January 23, 2013Research and Development, Sales and Marketing CDRD, LDC, translational research
Six of the world’s top health science centres have banded together in an attempt to speed up the rate at …
Roche adds head to corporate executive committee
January 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John Reed, Roche
Roche has announced that John Reed has been appointed as head of Roche Pharma Research and Early Development (pRED) and …
Ark Therapeutics mulling fundraising options
January 22, 2013Manufacturing and Production Ark Therapeutics
Contract development and manufacturing services company Ark Therapeutics has been forced to abandon proposals to raise money via an equity …
Germany’s Hameln warned by FDA over GMP failings
January 22, 2013Manufacturing and Production FDA, GMP, Hameln
German contract manufacturer Hameln Pharmaceuticals was sent a warning letter by the FDA last month detailing a number of Good …
Botox US bladder indication
January 22, 2013Sales and Marketing Allergan, Botox, FDA, bladder
Allergan’s Botox has been given approval by the FDA for the treatment of overactive bladder (OAB) in adults.Botox (onabotulinumtoxinA) has …
Lundbeck sells $100m portfolio
January 22, 2013Sales and Marketing Lundbeck, OTC, Panhematin, Recordati
Italian pharma group Recordati has paid $80 million to Lundbeck for a portfolio of products primarily aimed at the US …
New appointment and promotions at Events 4 Healthcare
January 22, 2013Medical Communications, Sales and Marketing Events 4 Healthcare
Comms agency Events 4 Healthcare has announced two new promotions and a new appointment to further enhance its team. Nicola …
Novartis eye drug nears approval
January 21, 2013Sales and Marketing AMD, CHMP, Jetria, Novartis
Novartis’ eye drug Jetrea has been given a positive opinion by the CHMP, pushing it to the brink of approval. …
CHMP nod for Pfizer CML drug
January 21, 2013Sales and Marketing CHMP, CML, FDA, Pfizer
Pfizer’s cancer drug bosutinib has been given a positive opinion by the CHMP for patients with chronic myelogenous leukemia (CML). …
Crohn’s and Colitis UK hire new chief executive
January 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Crohn's and Colitis, David Barker
The medical charity Crohn’s and Colitis UK Trustees have announced the appointment of David Barker as the new chief executive …
EU nod for Lilly brain diagnostic
January 18, 2013Research and Development, Sales and Marketing Alzhheimer's, Amyvid, brain, lilly
Eli Lilly’s diagnostic radiopharmaceutical Amyvid has been approved in Europe to assess whether patients have Alzheimer’s disease. Amyvid (Florbetapir F …
Roche’s Burgess to head up discovery at BMS
January 18, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Burgess
Bristol-Myers Squibb has appointed Mike Burgess as senior vice president, Discovery Medicine and Clinical Pharmacology. He will report to Francis …
Amgen earmarks $200m for new Singapore plant
January 18, 2013Manufacturing and Production Amgen, Merck, Singapore
Amgen has unveiled plans to construct a new manufacturing plant in Singapore, its first production facility in Asia. The biotechnology …
Biogen and Elan file for Tysabri first line use in MS
January 18, 2013Sales and Marketing Biogen IDEC, EMA, Elan, FDA, MS, Tsyabri, gilenya
Biogen Idec and Elan have applied to the FDA and EMA to expand Tysabri’s use in patients with relapsing forms …
MPs: ‘get on with VBP’
January 18, 2013Medical Communications, Sales and Marketing NHS, NICE, PPRS, VBP
An influential group of MPs has hit out at inactivity over moves towards value-based pricing (VBP), saying that the issue …
Senior sales appointment at Rieke Dispensing
January 18, 2013Manufacturing and Production, Research and Development, Sales and Marketing Nicolas Lemaigre-Voreaux, Rieke Dispensing
Packaging firm Rieke Dispensing has appointed Nicolas Lemaigre-Voreaux as its European Sales director to spearhead the company’s growth programme. Lemaigre-Voreaux …
Go digital health launched
January 17, 2013Medical Communications GolinHarris, Virgo, go digital health
A new global digital practice, go digital health, has been launched by Virgo Health and GolinHarris. The team brings together …
Latest content
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
